Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.
<h4>Objective</h4>Inflammatory bowel disease (IBD) is commonly treated with thiopurines such as azathioprine and mercaptopurine for the maintenance of remission. Studies examining chemopreventive of these medications on colorectal neoplasm in IBD patients have yielded conflicting results...
Saved in:
Main Authors: | Jianfeng Gong, Lijing Zhu, Zhen Guo, Yi Li, Weiming Zhu, Ning Li, Jieshou Li |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/df9b2eb1f85e470188f06a04de9ed493 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
by: Kanyarat Khaeso, et al.
Published: (2021) -
Vitamin D receptor FokI polymorphism and the risks of colorectal cancer, inflammatory bowel disease, and colorectal adenoma
by: Young Ae Cho, et al.
Published: (2018) -
The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer
by: Patrycja Kłos, et al.
Published: (2021) -
Microbiome-Mediated Immune Signaling in Inflammatory Bowel Disease and Colorectal Cancer: Support From Meta-omics Data
by: Molly Pratt, et al.
Published: (2021) -
Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series
by: Min Jee Kim, et al.
Published: (2021)